EVAX

Evaxion AS

• TipRanks·6h ago

  Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

• TipRanks·6h ago

  Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)

• TipRanks·6h ago

  Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01

• Benzinga·7h ago

  Evaxion Announces Final Patient Visit In One-Year Extension Phase 2 Trial Of Personalized Melanoma Cancer Vaccine EVX-01

• Reuters·7h ago

  Evaxion completes phase 2 EVX-01 trial extension; three-year data due H2 2026

• TipRanks·03/30 13:07

  Evaxion to Unveil AI-Designed Polio and CMV Vaccine Concepts at World Vaccine Congress

• Reuters·03/30 12:01

  Evaxion to present AI-designed next-generation polio vaccine concepts at World Vaccine Congress

• TipRanks·03/19 13:31

  Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations

• TipRanks·03/19 13:31

  Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting

• Reuters·03/19 13:01

  Evaxion shareholders to vote on board authority for DKK 73.5 million convertible loan notes

• Reuters·03/19 01:11

  Evaxion A/S CFO Thomas Frederik Schmidt files initial beneficial ownership statement

• Reuters·03/19 01:09

  Evaxion A/S files initial beneficial ownership statement for Chief AI Officer Andreas Holm Mattsson

• Reuters·03/19 01:08

  Evaxion A/S files Form 3 initial beneficial ownership statement for Chief Scientific Officer Birgitte Rono

• Reuters·03/19 01:07

  Evaxion A/S Director Lars Holtug Files Initial Statement of Beneficial Ownership

• Reuters·03/19 01:06

  Evaxion A/S CEO Helen Katrina Tayton-Martin files initial beneficial ownership statement